Document:

Amendment No. 1

 Exhibit 10.1 
  

			
	 	  	Portions of this Exhibit have been
omitted pursuant to a request for
confidential treatment. The omitted
portions have been marked
******** and have been filed
separately with the Commission

  
 AMENDMENT NO. 1

  
 Amendment No. 1, dated as of February 1, 2006
(this “Amendment”) to the License Agreement, dated as of November 13, 1998 (the “License”) by and between PG-TXL Company, L.P. (“LP”), a Delaware limited partnership having the principal place of business at 5124
Braeburn Drive, Bellaire, Texas 77401-4902 and Cell Therapeutics, Inc., a Washington corporation (“CTI”). 
  
 Preliminary Statement. The parties wish to amend the License primarily to alter the payment of certain potential milestones. For good and valuable
consideration, the receipt, sufficiency and adequacy as hereby acknowledged by the parties, the parties hereby agree as follows: 
  
 (the information marked by ******** has been omitted by a request for confidential treatment. The omitted portion has been separately filed with the Commission.)

  
 Section 1.0 Payment. Within five
(5) business days from the date hereof, CTI shall pay to LP $******** in cash to LP’s account at: 
  
 ******** 
 ******** 
 ******** 
 ABA/Routing and Transit #********

 Account Name: ******** 
 Account Number: ******** 

 Section 2.0 Amendments to License. The License is hereby amended as follows as of the
date hereof: 
  
 (a) Section 3.02.
Section 3.02 of the License is hereby amended to read in full as follows: 
  
 “SECTION 3.02. Milestone Payments. CTI shall make the following payments to PG-TXL within ten (10) business days, unless
otherwise noted, after the first achievement of each of the corresponding milestones (each milestone and corresponding payment shall be a stand-alone event and shall in no way be dependent upon the achievement of any other milestone): 
  

					
	 PG-TXL
 Milestone Event

	  	 PG-TXL
 Milestone
 Payment

	 
	 Oncology/PG-TXL
	  	 	 	 
	Successful Completion of a Phase II Clinical Trial in Japan	  	$	 *	*******
	Successful Completion of a Phase III Clinical Trial in the U.S. occurring after December 31, 2005	  	 	*	*******
	Successful Completion of a Phase III Clinical Trial in a Major Market Country or an EMEA country occurring after December 31, 2005	  	 	*	*******
	Successful Completion of a Phase III Clinical Trial in Japan	  	 	*	*******
	Thirty (30) business days after submission for Marketing Approval in a Major Market Country or with the EMEA that is accepted for filing/prosecution (i.e., not rejected) by the relevant
regulator in such Major Market County or by the EMEA	  	$	 *	*******
	Regulatory Approval for the first indication in the U.S.	  	 	*	*******
	Regulatory Approval for the first indication in a Major Market Country or any EMEA Country	  	 	*	*******
	Regulatory Approval for the first indication in Japan	  	 	*	*******
	 Additional Products:
	  	 	 	 
	Commencement of a Phase I Clinical Trial in the U.S. for the second compound protected by the PG-TXL Patent Rights	  	 	*	*******
	Commencement of a Phase I Clinical Trial in the U.S. for the third compound protected by the PG-TXL Patent Rights	  	 	*	*******

  
 (b)
Successful Completion. The definition of “Successful Completion” appearing in Section 1.01 of the License is hereby amended to read in full as follows: 
  
 “Successful Completion means, with respect to a Phase II or Phase III Clinical Trial, that
(i) such Clinical Trial has achieved each of its primary endpoints at a level that is statistically significant or (ii) Regulatory Approval is obtained in a listed jurisdiction regardless of the location(s) where such Clinical Trial was
carried out.” 

 (c) Section 15.11 of the License is hereby amended by adding the following
paragraph at the end thereof: 
  
 “If LP
believes that CTI is in default of a payment obligation under Section 3.02, it shall first give CTI written notice thereof setting forth in reasonable detail the bases for its conclusion. During the thirty (30) day period following
CTI’s receipt thereof, the parties shall attempt to resolve any differences. If, after expiration of such thirty (30) day period (or such longer period as the parties may agree), the parties shall not have reached a resolution, each party
may pursue any rights it may have hereunder including providing a notice of default under Section 12.02 (which notice shall have a date no earlier than the date of notice related to a purported default).” 
  
 Section 3.0 Amended Section 3.02 Governs. From and
after the date hereof, the parties hereto agree that the License, as amended hereby, shall govern any amounts due and owing under Section 3.02 of the License. Neither party shall have any rights or obligations under Section 3.02 prior to
the Amendment contemplated hereby and each party hereby agrees that all prior notices or claims that it may have had or made with respect to Section 3.02 of the License prior to this Amendment shall have not force or effect and are withdrawn.

  
 Section 4.0 Restricted Shares. Pursuant to
two letters each dated November 13, 1998, CTI granted to Sidney Wallace, M.D. and to Chun Li, M.D. certain rights to Restricted Shares and Restricted Share Rights, as defined therein. Within ten (10) business days after the date hereof,
CTI shall issue and deliver to Dr. Wallace all his remaining Restricted Shares and to Dr. Li all his remaining Restricted Shares. All such shares shall be without further restriction on vesting or transfer. 
  
 Section 5.0 Miscellaneous. This Amendment shall be
governed by and interpreted under the laws of the State of New York as applied to contracts entered into and performed entirely in New York by New York residents. The sections and paragraph headings contained herein are for purposes of convenience
only and are not intended to define or limit the contents of said sections or paragraphs. This Amendment may be executed in one or more counterparts (and by facsimile), each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. There are no covenants, promises, agreements, warranties, representations, conditions or understandings, either oral or written, between the parties other than as set forth herein and in the License Agreement
with respect to the subject matter hereof. All costs and expenses, including, without limitation, fees and disbursements of counsel, financial advisors and accountants, incurred in connection with this Amendment shall be paid by the party incurring
such costs and expenses. 
  
 IN WITNESS WHEREOF, LP and CTI have
caused this Amendment to be executed as of the date first written above by their respective officers thereunto duly authorized. 
  

			
	PG-TXL COMPANY, L.P.
		
	 By:
	 	Fem.CADeT Incorporated, its General Partner
	 	 	 
		
	 By:
	 	 /S/    SIDNEY WALLACE,
M.D.

	 Name:
	 	 Sidney Wallace, M.D.

	 Title:
	 	 President

			
	CELL THERAPEUTICS, INC.
		
	By:	 	 /S/    JAMES A.
BIANCO

	 Name:
	 	 James A. Bianco

	 Title:
	 	 President & Chief Executive OfficerExhibit 10.1

                              EMPLOYMENT AGREEMENT
                              --------------------

This Employment Agreement ("Agreement") made as of the "Effective Date" (defined
below), by and between Corporate Sports Incentives, Inc. d/b/a Utix Corporation,
Inc. ("Utix" or the "Company"), and Mark L. Pover (the "Executive").

In consideration of the mutual covenants and promises contained herein, and
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged by the parties hereto, the parties agree as follows:

I.       Title
         -----
         The Executive's title will be Chief Financial Officer.

II.      Term of Employment
         ------------------
         The Company hereby agrees to employ the Executive and the Executive
         hereby accepts employment with the Company for a period of one (1) year
         commencing on the Effective Date. At the end of the initial term, or
         any additional term, this Agreement shall automatically be extended for
         an additional one (1) year, unless either Executive or Company gives
         written notice to the other of its desire to terminate this Agreement
         at least six (6) months prior to the scheduled end of the term.

III.     Responsibilities of the Executive
         ---------------------------------
         The Executive agrees to undertake the duties and responsibilities
         inherent in the position described above, those described in the
         Company's By-Laws and such other duties and responsibilities as the
         Company shall from time to time reasonably assign. Executive shall
         report directly to the Chief Executive Officer. Executive shall devote
         his full time and best efforts to the Company. Any outside activities
         must be cleared with CEO in advance. Current outside activities must be
         approved and listed as part of this agreement.

IV.      Expense Reimbursement
         ---------------------
         The Company will advance and/or reimburse the Executive for all
         reasonable travel and other business expenses incurred in furthering
         the business of the Company and in accordance with the Company's travel
         and business expense policy. This will include reimbursement of cell
         phone expenses per company policy and professional fees and licenses,
         subject to CEO approval.

V.       Annual Base Salary
         ------------------
         The Executive shall receive an annual base salary of $192,000. This
         salary shall be reviewed periodically by the Compensation Committee of
         the Board; and the Board in its sole discretion, may increase the
         Annual Base Salary for part or all of the remaining term.

VI.      Bonuses
         -------

                                  Page 1 of 9

                                                        Company Initial: AGR
                                                                         ---

                                                      Executive Initial: MLP
                                                                         ---

<PAGE>

         Executive shall receive a fast start bonus of $8,000 for business
         planning, modeling and efficient transition of the finance function six
         months from the anniversary date of this agreement, per review and
         approval by CEO.

         Executive shall also participate in the Executive Bonus Program with a
         targeted Annual Bonus of 30% of the then Annual Base Salary. The Annual
         Bonus for Executive shall be payable in cash and will be due the month
         following the delivery of the Company's annual operating results to the
         Board of Directors.

         Such bonus is subject to performance evaluation and achievement of the
         following:

               o    Budget variance and general operating performance.
               o    Cost savings measures implemented.
               o    P&L performance versus plan with capitalization assumptions
                    fulfilled.
               o    Public company filings for accuracy, timeliness and
                    assistance with elevating the Company's listing.
               o    Execution of merger and/or acquisition transactions as
                    directed by the Board.

VII.     Stock Options
         -------------
         Executive is granted options pursuant to the Company's Stock Options
         Plan ("Plan") to purchase 1.5% issued and outstanding shares
         outstanding at time of employment. The exercise price shall be equal to
         the initial price established in the private offering of Company common
         stock made as of the Effective Date. Such options shall expire ten
         years from the date of issue. The options shall vest at the rate of 25%
         on the first anniversary of the grant and at a rate of 2.10% per month
         for the next 36 months thereafter, subject to Articles IX and XI below.

         Executive agrees to enter into a stock option agreement with Company
         containing the above terms and provisions of the options together with
         such other terms and conditions as counsel for the Company may
         reasonably require to assure compliance with applicable state and
         federal law and stock exchange requirements in connection with the
         issuance of Company common stock upon exercise of options to be granted
         as provided herein, or as may be required to comply with the Plan.

VIII.    Benefits
         --------
         Executive shall be entitled to receive all benefits generally made
         available to senior executives of the Company ("Benefits"). Executive
         shall receive four weeks of vacation annually upon completion of first
         six month period of employment.

IX.      Termination by Company
         ----------------------
         Company shall have the right to terminate this Agreement under the
         following circumstances:

                                  Page 2 of 9

                                                        Company Initial: AGR
                                                                         ---

                                                      Executive Initial: MLP
                                                                         ---

<PAGE>

               A.   For cause upon notice from the Company Board of Directors.
                    For purposes hereof, "cause" for termination shall include
                    (a) embezzlement, theft, larceny, material fraud, or other
                    acts of dishonesty; (b) conviction of or entrance of a plea
                    of guilty or nolo contendere to a felony or other crime
                    which has or may have a material adverse effect on the
                    Executive's ability to carry out his duties under this
                    Agreement or upon the reputation of the Company; (c) conduct
                    involving moral turpitude; and (d) upon a good faith finding
                    by the Board of Directors of gross insubordination or
                    misconduct during the term hereof which materially harms or
                    damages the Company.

               B.   Upon the death or disability of the Executive. As used in
                    this Agreement, the term "disability" shall mean the
                    inability of the Executive, due to a physical and/or mental
                    disability, to perform the essential functions of his/her
                    job for a period of six (6) consecutive months.

               C.   For poor performance of Executive as determined by the Board
                    of Directors, after (i) such performance issues have been
                    communicated in writing to the Executive and (ii) the
                    Executive has failed to cure deficiencies communicated
                    within a reasonable time period.

X.       Rights Following Termination by Company
         ---------------------------------------
         Upon termination of Executive by Company, the following shall apply:

         Upon termination pursuant to Paragraph A ("for cause") of Section IX,
         the Company shall have no further responsibility to Executive except to
         pay the portion of (i) the Annual Base Salary, and (ii) Annual Bonus
         earned and pro-rated to and including the last day of employment shall
         be paid to Executive in accordance with bonus payment schedules of
         other Executives. All stock options not yet vested as of the last day
         of employment are canceled.

         Upon termination pursuant to Paragraph B ("death or disability") of
         Section IX, the Company shall continue to pay to the Executive, his
         surviving spouse, if living, otherwise to his estate, the Annual Base
         Salary plus his any accrued bonus which shall be computed at a rate of
         110% of the previous years bonus prorated for the partial year or an
         amount as negotiated between the parties and provide full benefits
         (pursuant to Article VIII) for nine (9) months following the last day
         of employment in the event of Executive's death or from the date the
         Executive is deemed disabled (as defined in Section IX B).

         Upon termination of this agreement or termination pursuant to Paragraph
         C ("poor performance") of Section IX, the Company shall provide
         Executive with the following severance package:

                                  Page 3 of 9

                                                        Company Initial: AGR
                                                                         ---

                                                      Executive Initial: MLP
                                                                         ---

<PAGE>

               o    Base Salary and Benefits and Annual Bonus for a period of
                    nine (9) months following the date of termination. Base
                    Salary continuation payments shall be payable either in a
                    lump sum within 10 days from the date of termination or as
                    otherwise scheduled as negotiated by the parties. Benefits
                    will continue to be paid by the Company in full for the nine
                    (9) month period following termination. Bonuses shall be
                    paid to Executive in a lump sum within 10 days from the date
                    of termination and shall be computed at a rate of 110% of
                    the previous years bonus prorated for the partial year or an
                    amount as negotiated between the parties.

               o    All stock options, warrants, restricted stock and other
                    equity arrangements vested as of the date of termination,
                    pursuant to the terms of Section X and Paragraph C of
                    Section IX hereof, remain with Executive and 50% of the
                    then-remaining unvested portion of the restricted stock
                    shall automatically become vested and granted, all remaining
                    unvested restricted stock grants shall be canceled

XI       Termination by Executive
         ------------------------
         Executive shall have the right to terminate his employment under this
         Agreement upon thirty (30) days' prior written notice to Board provided
         said notice is delivered to the Chairman of the Board within 60 days
         following the occurrence of either A below or resigns in accordance
         with B below.

         A.   Company materially reduces Executive's title, scope of authority,
              duties or responsibilities hereunder or modifies this agreement
              without Executive's written consent. Executive's principal
              workplace is relocated such that Executives commute is increased
              by more than 20 miles. Executive's scope of authority, duties or
              responsibilities shall not be deemed materially reduced for
              purposes hereof solely by virtue of the fact that Company is (or
              substantially all of its assets are) sold to, or is combined
              with, another entity provided that following such an event (i)
              Executive shall continue to have the same scope of authority,
              duties and responsibilities with respect to Company's Universal
              Ticket products, sales and marketing operations, and retail
              distribution business and (ii) Executive shall report directly to
              the then Chief Executive Officer or Board of Directors of the
              entity that acquires the Company or substantially all of its
              assets; or

         B.   Executive announces the termination of his employment agreement
              in writing to the Board of Directors as a "voluntary
              resignation."

XII      Rights Following Termination by Executive
         -----------------------------------------
         If this Agreement is terminated pursuant to Sections A of Article XI,
         the Company shall pay Executive within 30 days of the date of
         termination the following severance package:
               o    Base Salary and Benefits and Annual Bonus for a period of
                    nine (9) months following the date of termination. Base
                    Salary continuation payments shall be payable either in a
                    lump sum within 10 days from the date of termination or as

                                  Page 4 of 9

                                                        Company Initial: AGR
                                                                         ---

                                                      Executive Initial: MLP
                                                                         ---

<PAGE>

                    otherwise scheduled as negotiated by the parties. Benefits
                    will continue to be paid by the Company in full for the nine
                    (9) month period following termination. Bonuses shall be
                    paid to Executive in a lump sum within 10 days from the date
                    of termination and shall be computed at a rate of 150% of
                    the previous years bonus prorated for the partial year or an
                    amount as negotiated between the parties.

               o    All stock options, warrants, restricted stock and other
                    equity arrangements vested as of the date of termination
                    remain with Executive and 100% of the then-remaining
                    unvested portion of the restricted stock shall automatically
                    become vested and granted. .

         If this Agreement is terminated pursuant to Section B of Article XI
         (voluntary resignation), the Company shall have no further
         responsibility to Executive except to pay the portion of (i) Annual
         Base Salary, and (ii) Annual Bonus earned to and including the last day
         of employment and any statutory benefits. Further, all stock options
         not yet vested as of the last day of employment are canceled. All stock
         options, warrants and other equity arrangements vested as of the date
         of termination remain with Executive and Executive has 90 days from the
         date of termination to exercise all such options, warrants or other
         equity arrangements. As of the 91st day following the date of
         termination, all unexercised options, warrants and other equity
         arrangements shall be canceled.

XIII.    Change of Control Termination
         -----------------------------
         If within twelve months following a Change of Control, as hereinafter
         defined, the Executive's employment is terminated for a reason (or no
         reason) other than for disability, death or for cause, the termination
         shall be deemed a "Change of Control Termination" and this Article
         shall determine Executive's severance package in lieu of provisions
         described under Articles X and XII above. In the event of a Change of
         Control Termination, the Company shall pay to the Executive; (i) Base
         Salary and Benefits (pursuant to Article VIII) and Annual Bonus for a
         period of twelve (12) months following the date of termination. Base
         Salary continuation payments shall be payable either in a lump sum
         within 10 days from the date of termination or as otherwise scheduled
         as negotiated by the parties. Benefits will continue to be paid by the
         Company in full for the twelve (12) month period following termination.
         Bonuses shall be paid to Executive in a lump sum within 10 days from
         the date of termination and shall be computed at a rate of 150% of the
         previous year's bonus or an amount as negotiated between the parties
         but in no event shall such amount be less than 60% of the Executive's
         then current Base Salary, and (ii) All stock options, warrants,
         restricted stock and other equity arrangements vested as of the date of
         termination remain with Executive and 100% of the then-remaining
         unvested portion of all stock options, warrants, restricted stock and
         any other equity arrangements shall automatically become vested,
         exercisable and/or granted as the case may be.

                                  Page 5 of 9

                                                        Company Initial: AGR
                                                                         ---

                                                      Executive Initial: MLP
                                                                         ---

<PAGE>

         "Change of Control" shall be deemed to have occurred if at any time
         after the Effective Date of this Agreement any person or group
         (excluding the shareholders of the Company the date before the Public
         Merger), directly or indirectly, controls more than 50% of the combined
         voting power of the voting securities of the Company.

XIV.     Binding Agreement
         -----------------
         This Agreement shall be binding upon and inure to the benefit of
         Executive, his heirs, distributes and assigns and the Company, its
         successors (e.g. Public Company via Public Merger), and assigns.
         Executive may not, without the express written permission of the
         Company, assign or pledge any rights or obligations hereunder to any
         person, firm or corporation. No amendment or modification of this
         Agreement shall be valid unless evidenced by a written instrument
         executed by both parties hereto.

XV.      Governing Law
         -------------
         This Agreement shall be governed by and construed in accordance with
         the laws of the State of Delaware.

         All notices which a party is required or may desire to give to the
         other party under or in connection with this Agreement shall be given
         in writing via either overnight service or U.S. Mail certified return
         receipt requested, by addressing the same to the other party as
         follows:

                  If to Executive to:
                                    Mark L. Pover
                                    3 Mildred Circle
                                    Sturbridge, MA 01566

                  If to Company to:
                                    Anthony G. Roth, CEO
                                    Utix Corporation
                                    7 New England Park, Suite 610
                                    Burlington, MA 01803

                  Or such other place as may be designated in writing by like
                  notice.

XVI      Confidential Information of Utix and its Clients
         --------------------------------------------------
         In the course of my employment by the company, I may become aware of
         confidential information relating to the business of Utix or its
         clients. I will never use or disclose any confidential information of
         Utix or any of its customers, including, without limitation, customer
         lists, market research, strategic plans or other information or
         discoveries, inventions, improvements, know-how, methods or other trade
         secrets, whether developed by me or others. I will comply with the
         Company's policies and procedures for the protection of confidential
         information.

                                  Page 6 of 9

                                                        Company Initial: AGR
                                                                         ---

                                                      Executive Initial: MLP
                                                                         ---

<PAGE>

         Further, my obligation not to disclose or use such confidential
         information will continue for a period of five years after the
         termination of my employment.

XVII     Intellectual Property
         ---------------------
         The term "intellectual property," as used in this paragraph, includes
         all inventions, discoveries, concepts, ideas, systems, methods,
         processes, works, computer programs, and computer software (whether or
         not patentable or copyrightable or constituting trade secrets). I will
         promptly disclose to the Company, and hereby agree to assign to the
         Company all of my full right, title and interest in all "intellectual
         property" conceived of or created by other employees of Utix or by
         clients of Utix during the period of my employment by the Company. I
         understand that I will have no rights to any royalties or other
         compensation for the use of any intellectual property covered by this
         Agreement, unless expressly agreed to in writing by the Company.

         However, this paragraph 3 shall not apply to "intellectual property"
         that meets all of the following requirements: (i) it does not relate to
         the actual business (or business under consideration that is known to
         me) or research and development of Utix, (ii) it is made or conceived
         of by me during the times of not working as an employee of the Company
         (whether or not during the normal business hours or on Company
         premises), and (iii) it is not derived from, and is made without the
         use of, any intellectual property or confidential information of Utix.

XVIII    Patents
         -------
         If so requested by the Company, I will cooperate with the Company in
         doing whatever is appropriate to apply for, obtain and enforce patents
         (U.S. or foreign or both) for the Company or its clients, on any
         inventions which are made by me (either alone or jointly with other)
         during the period of employment. This obligation will continue after
         termination of my employment, provided that (a) all expenses required
         to apply for, obtain and enforce any patents will be paid by the
         Company, and (b) if I am required to spend any substantial amount of
         time to carry out my obligations, I will be entitled to reasonable
         compensation from the Company for that time. I understand that the
         Company will have no obligation to me to apply for or obtain any such
         patents.

XIX      Writings
         --------
         Any written, printed materials or software while I prepare during the
         course of my employment and solely related to the direct business of
         the Company will be the property of the Company, and if so requested by
         the Company, I will do whatever is appropriate to obtain copyright
         protection for such materials for the benefit of the Company. I will
         not publish or cause the publication of any written or printed
         materials relating to my work for Utix or its clients without the prior
         written approval of the Company. All copyrightable works that I create
         during the term of the agreement and for the sole benefit of the
         Company shall be considered "works made for hire."

                                  Page 7 of 9

                                                        Company Initial: AGR
                                                                         ---

                                                      Executive Initial: MLP
                                                                         ---

<PAGE>

XX       Company Property
         ----------------
         Upon the termination of my employment (or during my employment, if so
         requested by the Company), I will deliver to the authorized
         representative of the Company (a) all credit cards, identification
         cards, badges, keys and other items which have been provided to me by
         the Company, (b) all tools, equipment, and software provided to me by
         the Company and (c) all the written and printed materials, records,
         tapes and other media which relate to the business of the Company. I
         will not retain any copies of duplicates of the items described above,
         except that I may retain copies of my own records relating to my
         compensation from the Company, a copy of this Employee Agreement (and
         any related amendments), documents related to Executive's equity
         ownership, and my personal copies of any papers or correspondence which
         have been written by me and have been published without restriction. In
         the event that I fail to return any company property upon termination
         of my employment or as otherwise directed, I authorize the Company to
         offset the replacement cost of such property from my wages.

XXI      Non-Compete
         -----------
         In recognition of the sensitivity of the confidential and proprietary
         information of Utix to which I have access during my employment with
         the Company, and the degree of competition in the fields in which Utix
         has chosen to engage, I agree that, for a period of one year after the
         date of termination of my employment with the Company for any reason
         (the "Restricted Period") , I will not engage in any business, whether
         as an employee, consultant or otherwise that is competitive with any
         business activity of Utix with which I was directly involved during the
         past six months of employment with Utix. Further, I will not accept
         employment or a consulting position with any business which is, or at
         any time within one year prior to my termination, was a customer of
         Utix without the prior written consent of the CEO or other authorized
         executive of Utix. I may, however, own 5% or less of the securities of
         any publicly traded company.

XXII     Soliciting Employees and Clients
         --------------------------------
         I agree that while the Company's employ, and thereafter during the
         Restricted Period, I will not, and will not assist anyone else to,
         directly or indirectly, solicit or induce any of Utix's employees to
         terminate their employment with Utix or divert or take away from Utix
         any person, company or entity which on the date hereof is, or hereafter
         during the term of my employment by the Company becomes a customer,
         client, supplier or independent contractor of Utix.

XXIII    Effective Date
         --------------
         This Agreement shall become effective and all terms and conditions in
         full force as of January 23, 2006. . Executive shall have a start date
         of March 1, 2006 and shall use the time between the effective date and
         the start date to transaction his other activities. During the
         transition period, Executive shall use his best efforts to make himself
         available to the Company on an as needed basis. All terms and
         conditions of this agreement shall be in full force as of the effective

                                  Page 8 of 9

                                                        Company Initial: AGR
                                                                         ---

                                                      Executive Initial: MLP
                                                                         ---

<PAGE>

         date of this agreement, however during the transition period, executive
         shall receive compensation in accordance with Section XXV, Transition
         Compensation.

XXIV     Attorney Fees
         -------------
         In the event a dispute arises as to the interpretation, enforcement
         and/or breach of this Agreement, the prevailing party shall be entitled
         to reasonable attorney's fees and all cost incurred.

XXV      Transition Compensation
         -----------------------
         The Company has requested that the Executive be available to the
         Company in the period as of the effective date and prior to the
         executives start date, ("Transition Period"). All of the terms and
         conditions of this agreement shall remain in full force as of the
         effective date of this agreement, however during this Transition
         Period, Executive shall be compensated at a rate of $125 per hour plus
         expenses, for his services provided to the Company.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
23rd day of January, 2006.

EXECUTIVE:                              Utix Group, Inc.

/s/ Mark L. Pover                       /s/ Anthony G. Roth
----------------------------------      --------------------------------------
Mark L. Pover         Date              Anthony G. Roth           Date
                                        President & CEO

Exhibit A

Executive's Outside Activities approved in accordance with Section III.

Board and/or Advisor:

Emergent Game Technologies, Inc.
G2G Entertainment, Inc.

                                  Page 9 of 9

                                                        Company Initial: AGR
                                                                         ---

                                                      Executive Initial: MLP
                                                                         ---

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]